Schonfeld Strategic Advisors LLC Dyne Therapeutics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 115,195 shares of DYN stock, worth $3.85 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
115,195
Previous 269,757
57.3%
Holding current value
$3.85 Million
Previous $7.66 Million
46.92%
% of portfolio
0.03%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
203Shares Held
106MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$268 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$262 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$247 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$213 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$202 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.73B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...